Award details

Integration of lipid and protein kinase signalling in primary cilia biology

Reference	BB/W007460/1
Principal Investigator / Supervisor	Professor Bart Vanhaesebroeck
Co-Investigators / Co-Supervisors	Dr Sarah Conduit
Institution	University College London
Department	Oncology
Funding type	Research
Value (£)	472,722
Status	Current
Type	Research Grant
Start date	01/02/2022
End date	31/01/2025
Duration	36 months

Abstract

Primary cilia are antenna-like organelles which are critical for cell signalling during development and homeostasis and are deregulated in hereditary diseases called ciliopathies. The mechanisms regulating cilia function and assembly/disassembly dynamics remain incompletely understood. The PIP3 lipid localises to the cilia transition zone but the role it plays, mechanisms by which it functions and how it is produced at this site are poorly characterised. Class I PI 3-kinases (PI3Ks) generate PIP3 to regulate cell growth, proliferation and migration and have been extensively linked to disease including overgrowth syndromes. We have discovered that the class I PI3Ks contribute to the PIP3 pool at the transition zone. We aim to elucidate which class I PI3K(s) are required for transition zone PIP3 production and uncover the mechanism of action of transition zone PIP3 by: 1. Determining the PI3K isoform responsible for transition zone PIP3 2. Defining the consequences of PI3K activation on cilia signalling 3. Elucidating the role PIP3 plays in transition zone barrier function 4. Understanding the molecular mechanism by which increased cilia-associated PIP3 induces cilia disassembly Experimentally this will involve: 1.Cilia model systems: a. Assessing the effect of class I PI3K isoform specific inactivation/inhibition of ciliary PIP3 levels b. Assessment of cilia signalling output and crosstalk with PI3K c. Identification and characterisation of PIP3 regulated proteins at the transition zone d. Identification of key pathways involved in serum-induced cilia disassembly e. Assessment of signalling downstream of PIP3 in cilia disassembly 2.PIK3CA mutant vascular malformation model systems a. Analysis of cilia assembly/disassembly dynamics b. Investigation of relevant targets identified in the cilia model systems Our proposal has the clear potential to increase the knowledge of fundamental processes in cell biology and disease

Summary

This proposal will investigate PI 3-kinases (PI3Ks in short) that regulate fundamental processes in cells. Our laboratory has played a leading role in finding out the roles of the different PI3K family members in the body, how they work and how drugs against some of them can be developed to treat human disease in which PI3K is deregulated. Inhibitors against PI3K family members, including a PI3K family member we discovered, are now approved for the treatment of leukaemia and breast cancer. Our studies focus on the so-called class I PI3K family members which have been extensively studied and implicated in disease, including in cancer and overgrowth syndromes, which are a group of diseases where different body tissues become large and abnormal, often including the blood vessels. Despite extensive of research, key elements of PI3K biology are poorly understood, in part because we believe their function has not been investigated in the appropriate conditions and models. Our proposal focuses on a much-overlooked organelle in cells, called the primary cilium. This is a small antenna-like structure that projects out of each cell to sense the environment and is important for development and normal adult cell and tissue function. Recent studies including our preliminary experiments investigating PI3K in relevant cell conditions have identified a new function for these proteins in controlling the primary cilium. The lipid that class I PI3Ks produce (known as PIP3) localises to primary cilia. However, it remains unknown which class I PI3K(s) are important for this PIP3 and how PI3Ks and PIP3 control cilia function. We will investigate these fundamental biological questions using well-established primary cilia model systems in which we have previous experience, then explore if our findings relate to overgrowth syndromes and may help to treat this condition. We believe our findings have the potential to uncover insight into long-standing questions in cilia biology and helpto understand how increased activity of PI3K contributes to disease, including overgrowth syndromes. Understanding the mechanistic basis of disease informs and is essential for the process of drug/medicine development. Overgrowth conditions are poorly treated and disease mechanisms we identify may show how already existing drugs can be used in these conditions but also reveal new drug targets for development.

Committee	Research Committee D (Molecules, cells and industrial biotechnology)
Research Topics	X – not assigned to a current Research Topic
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search